| Bioactivity | Nexopamil is a calcium antagonist of Ca2+ channel, 5HT2, 5HT1A, 5HT1C and dopamine D2 receptors. Nexopamil exhibits vasodilatory, cardioprotective, and platelet aggregation inhibiting effects. Nexopamil can be used for researches of stable or unstable angina and possibly of peripheral arterial occlusive disease[1]. |
| CAS | 136033-49-3 |
| Formula | C24H40N2O3 |
| Molar Mass | 404.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Michael K, et al. Nexopamil (LU 49938), A Combined Ca2+ Channel Blocker and 5HT2 Receptor Antagonist. Cardiovascular Drug Reviews. Sep 1994 |
Nexopamil
CAS: 136033-49-3 F: C24H40N2O3 W: 404.59
Nexopamil is a calcium antagonist of Ca2+ channel, 5HT2, 5HT1A, 5HT1C and dopamine D2 receptors. Nexopamil exhibits vaso
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.